project id: TCGA-UCEC; case submitter id: TCGA-AX-A1CR; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.6; rna integrity number: 7.1; spectrophotometer method: UV Spec; age at index: 70; days to birth: -25812; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1940; age at diagnosis: 25812; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 701.0; figo stage: Stage IIB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: Not Reported; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 274; initial weight: 110.0; oct embedded: false; preservation method: Unknown; sample id: 8d14edd5-b754-48af-b636-4e655fce9cbe; sample submitter id: TCGA-AX-A1CR-01A; portion id: 0889964c-c9e1-417c-949f-23ee9d0a74de; portion submitter id: TCGA-AX-A1CR-01A-12; slide id: fb507ade-f7a1-44e0-8ace-7b1f60b368c9; slide submitter id: TCGA-AX-A1CR-01A-01-TS1; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 0.0; percent necrosis: 1.0; percent neutrophil infiltration: 1.0; percent normal cells: 10.0; percent stromal cells: 9.0; percent tumor cells: 80.0; percent tumor nuclei: 88.0; section location: TOP;